Corneal Graft Rejection
📧 Sign up to get email alerts when something new happens for Corneal Graft Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: CD160 Expression in Corneal Vessels
A completed clinical trial investigating CD160 expression in corneal vessels in the context of corneal graft rejection.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
A nationwide registry is being developed to track longitudinal clinical outcomes after corneal surgery and in corneal disease, including gra…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Neovascularization Patterns in Corneal Graft Rejection
Completed clinical trial examining neovascularization patterns during corneal graft rejection.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty [NA]
Completed clinical trial suggests that prolonged topical corticosteroid treatment after low-risk penetrating keratoplasty may reduce graft r…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection [NA]
This clinical trial update assesses whether 2% cyclosporine eye drops can prevent corneal graft rejection; the status and results are not pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-10-11Clinical Trial Update: Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk [Phase 3]
The Phase 3 study LX201 for prevention of corneal allograft rejection in high-immunological-risk subjects has been terminated. The update do…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty [Phase 3]
Phase 3 study of LX201 to prevent corneal graft rejection after penetrating keratoplasty was terminated.